Overview
Clinical Meaning
CKD staging by eGFR (CKD EPI): G1 ( =90 with albuminuria), G2 (60 89), G3a (45 59), G3b (30 44), G4 (15 29), G5 (<15).
AGPCNP
AGPCNP
CKD staging by eGFR (CKD-EPI): G1 (>=90 with albuminuria), G2 (60-89), G3a (45-59), G3b (30-44), G4 (15-29), G5 (<15). Albuminuria staging: A1 (<30), A2 (30-300), A3 (>300 mg/g). Progressive nephron loss activates RAAS increasing intraglomerular pressure. SGLT2 inhibitors reduce hyperfiltration via tubuloglomerular feedback. Complications: anemia (decreased EPO), CKD-MBD (secondary hyperparathyroidism), metabolic acidosis, hyperkalemia.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this AGPCNP pathway. You can still explore topic-filtered questions from the bank hubs below.